Soxil Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 03-07-2024
- Paid Up Capital ₹ 2.00 M
as on 03-07-2024
- Company Age 40 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.49 Cr
as on 03-07-2024
- Satisfied Charges ₹ 2.50 Cr
as on 03-07-2024
- Revenue 0.08%
(FY 2023)
- Profit 14.67%
(FY 2023)
- Ebitda 14.21%
(FY 2023)
- Net Worth 10.35%
(FY 2023)
- Total Assets 13.36%
(FY 2023)
About Soxil Drugs And Pharmaceuticals
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹3.49 Cr. The company has closed loans amounting to ₹2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vishnu Choudhary and Usha Choudhary serve as directors at the Company.
- CIN/LLPIN
U24232RJ1984PTC003121
- Company No.
003121
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 1984
- Date of AGM
24 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Ajmer, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Soxil Drugs And Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishnu Choudhary  | Director | 12-Dec-2013 | Current |
| Usha Choudhary | Director | 12-Dec-2013 | Current |
Financial Performance of Soxil Drugs And Pharmaceuticals.
Soxil Drugs And Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 0.08% increase. The company also saw a substantial improvement in profitability, with a 14.67% increase in profit. The company's net worth Soared by an impressive increase of 10.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Soxil Drugs And Pharmaceuticals?
In 2023, Soxil Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shree Ajeypal Herbal And Pharmaceuticals Private LimitedActive 14 years 5 monthsUsha Choudhary is a mutual person
Jajot Enterprises Private LimitedActive 14 years 3 monthsVishnu Choudhary and Usha Choudhary are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 13 Sep 2023 | ₹3.49 Cr | Open |
Others Creation Date: 30 Jul 2020 | ₹3.99 M | Satisfied |
Others Creation Date: 31 Dec 2019 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Soxil Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Soxil Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Soxil Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Soxil Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
